Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 14648027 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | fludarabine | NA | only_studied | |
| NA | |||||||
| 14676778 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| registries and cord blood banks around the world collect and store the hla types of volunteers in order to identify matched unrelated donors for patients requiring hematopoietic stem cell transplantation. | |||||||
| 14730333 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | Spanish | NA | NA | negative | |
| over a 3-year period, 145 patients ineligible for myeloablative conditioning underwent reduced-intensity conditioning (ric) hematopoietic stem cell transplantation (sct) from an hla-identical sibling in a prospective study. | |||||||
| 14750078 | HLA-A (HLA-A) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| which donor should be chosen for hematopoietic stem cell transplantation among unrelated hla-a, -b, and -drb1 genomically identical volunteers? | |||||||
| 14750078 | HLA-DRB1 (HLA-DRB1) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| which donor should be chosen for hematopoietic stem cell transplantation among unrelated hla-a, -b, and -drb1 genomically identical volunteers? | |||||||
| 14755317 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | methotrexate | NA | negative | |
| feasibility of reduced intensity hematopoietic stem cell transplantation from an hla-matched unrelated donor. | |||||||
| 15218416 | HLA MATCHED (HLA-MATCHED) | retinoic | NA | doxorubicin | NA | unclassified | |
| NA | |||||||
| 15314891 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| first line treatment for severe aa consists of hematopoietic stem cell transplantation in young patients with hla identical siblings, while immunosuppression therapy is used for older patients and for those of any age who lack a hla matched donor. | |||||||
| 15748442 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| both of them underwent hla-matched/mismatched sibling hematopoietic stem cell transplantation (hsct). | |||||||
| 15777111 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| t-cell depletion and the hla-mismatched donor and recipient are the main risk factors following hematopoietic stem cell transplantation. | |||||||
Copyright 2024